Rockwell Medical Inks Major Purchase Agreement

WIXOM, MI – Rockwell Medical, Inc. (NASDAQ:RMTI), a leading player in the hemodialysis product market, has secured a significant product purchase agreement with a top global dialysis product and service provider.

Market Impact

Shares surged nearly 15% in pre-market trade on Tuesday.

Key Details

The company, recognized as the primary supplier of liquid bicarbonate in the United States, will supply its SteriLyte® liquid bicarbonate hemodialysis concentrates to the unnamed leading customer.

This deal spans an initial term of three years, with the potential for two additional one-year renewals, and is expected to generate over $10 million in net sales for Rockwell Medical in the first year alone. This figure surpasses the sales projections previously announced for the year 2025. The agreement also entails planned price increases for each subsequent year.

Company Remarks

Rockwell Medical's President and CEO, Mark Strobeck, Ph.D., expressed excitement about the extended partnership, emphasizing the customer's dedication to improving patient quality of life through high-quality products and innovative healthcare solutions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.